Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure (ATOMIC-AHF)

NCT01300013 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

614

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Placebo
DRUG: Omecamtiv mecarbil

Sponsor

Cytokinetics